Related by context. All words. (Click for frequent words.) 77 Survival Protein modulation 67 innovative Activated Checkpoint 67 oncolytic virus therapies 64 ON WARRANTY SHOULD 63 ® Cortizone 61 rxRNA 61 HuMax Wnt 61 including Abra ACCPAC 60 Zicam Cold Remedy RapidMelts 60 personalized cellular immunotherapy 60 Its THOR LVX 60 Shows Promise Against 59 taxane derivative 59 novel VDA molecule 59 triciribine phosphate monohydrate 59 Fc fusion protein 59 single blastomere 59 small molecule tyrosine 59 NATIONAL CIRCUIT FORREST 59 PHASE III 59 liposomal formulation 59 chimeric monoclonal antibody 58 dasatinib Sprycel 58 legendary SPACE INVADERS 58 PSMA ADC 58 LungSign TM 58 delipidation 58 orally inhaled migraine 58 Ceragenin ™ 58 onset AF 58 PRIVATE SECURITIES LITIGATION REFORM 58 inflammatory demyelinating 58 Evaluation Program CTEP 57 Squalamine 57 com BlackSingles.com R 57 Marie Callender Egg Beaters 57 Rose Rennekamp 57 tenofovir disoproxil fumarate Viread 57 Selective Electrochemical Tumor Ablation 57 Prednisone Against Refractory 57 isoform selective 57 CCR9 antagonist 57 ENMD # 57 Biomarker Study 57 MVA BN 57 THE GERMAN SECURITIES 57 Unisom ® 57 histone deacetylase HDAC 56 ovarian cancer chronic hepatitis 56 fosbretabulin 56 novel nucleoside analog 56 Novel Antibody 56 mTOR mammalian target 56 subcutaneous immunoglobulin 56 PDE4 inhibitor 56 BHT DNA 56 Endovascular System 56 Vidofludimus 56 eTag assays 56 omacetaxine mepesuccinate 56 Healthy Eating Made Easier 56 methylation profiling 56 THEIR BE 56 IgG1 antibody 56 Aerosurf 56 tubulin inhibitor 56 pan histone deacetylase 56 novel histone deacetylase 56 THAT ARE DIFFICULT TO 56 Tesmilifene 56 GLP toxicology studies 56 immatics 56 Biomerk Tumorgrafts 56 predictive toxicology 56 selective agonist 55 Trofex 55 CTx 55 evaluating Actimmune 55 AMPK activators 55 OvaRex R 55 Phase IIa trials 55 Modrenal 55 antiangiogenic agent 55 pharmacological chaperone 55 Context Tracking 55 robust interlibrary loan 55 LHRH antagonists 55 PrevOnco ™ 55 Initiates Clinical Trial 55 synthetic retinoid 55 BY WILLA J. 55 JAK#/JAK# 55 Proc Am Soc 55 Anticalin R 55 PI3K/mTOR 55 Bosutinib 55 R BorderGuard 54 Pentraxin 2 54 Gleevec resistant 54 MGMT methylation 54 systemic RNAi 54 PROMACTA ® 54 BrachySil TM 54 Aeolus Pharmaceuticals Announces 54 vascular disrupting agent 54 Genisphere 54 Lotus Notes Novell GroupWise 54 R Rituximab Herceptin 54 Phase Ib Clinical Trial 54 Proteasome 54 peptide conjugated 54 Atridox R Atrisorb 54 Medarex logo 54 patented Modular Cartridge 54 cMET 54 Node Positive 54 IN FIGHT AGAINST 54 Therapeutic Antibody 54 Kevetrin ™ 54 RNAi Therapeutic 54 OvaRex MAb 54 Adjuvant Colon Cancer 54 triphendiol 54 punctal plug delivery 54 individualized cellular immunotherapy 54 novel oral anticoagulant 54 CB2 selective 54 targeting PCSK9 54 successfully commercialize Iluvien 54 ThermoDox ® clinical 54 Aurora kinase inhibitor 54 TransVax tm 54 BRAF inhibitors 54 HQK 54 neuronal nicotinic receptor NNR 54 vascular disrupting agents 54 DepoVax ™ 54 Grid caBIG 54 oxidative stress inducer 54 immune modulating 54 cannabinor 54 OncoVEX 54 Platinum Resistant Ovarian 54 inhibits VEGF 53 GAMMAGARD 53 Transmembrane 53 OnDose 53 Cand5 53 HYPERTENSION 53 selectively inhibited 53 Therapeutic Efficacy 53 Drug Shows Promise 53 anti angiogenic agent 53 Anticalin 53 HuCAL antibodies 53 TKM PLK1 53 Tarvacin TM 53 RDS ® InCup 53 Phase 1a clinical 53 Sequencing Systems 53 Zicam Extreme 53 Preclinical Study 53 PATRICK CORRIGAN TORONTO 53 TAKSTA 53 'S ® DOLMIO 53 biosimulation 53 Therapeutic Diagnostics 53 preclinically 53 JAK2 inhibitors 53 Estrogen Receptor 53 pharmacophore 53 HONORED WITH 53 preclinical efficacy 53 R roscovitine 53 THEO TORONTO 53 Helps Diagnose 53 EDEMA3 53 NeuVax 53 CCX# 53 PathFinderTG 53 Phase III multicenter 53 IN PATIENTS WITH 53 FBPase 53 RH1 53 Referenced EEG 53 Sipuleucel T 53 AND BE READY 53 HEY ROCK 53 TAXUS TM 53 Human Leukocyte Antigen 53 Human Neural Stem 53 lenalidomide dexamethasone 53 Small Molecules 53 Vaccine Shows Promise 53 ® natalizumab 53 Processing Workstation 53 'S ABILITY TO 53 Test Detects 53 HERmark assay 53 TroVax ® 53 Aplidin 53 Potelligent Technology 53 PEP# [003] 53 therapy Tovaxin 53 milnacipran HCl 53 RIVA D. 53 Cimzia TM 53 allergic airway inflammation 53 EGS# 53 Panzem R NCD 53 artemisinin combination 53 trial evaluating OrCel 53 ALN HTT 53 NOTE Sirenza Microdevices 52 DIGITAL SIGNAGE 52 TriGrid ™ 52 Aortic Dissection 52 peptidomimetic 52 Zemplar Capsules 52 Epitopes 52 A3 adenosine receptor 52 K ras mutations 52 Novel Therapeutic 52 JAK inhibitors 52 College Readiness Benchmarks 52 EORTC NCI 52 antisense inhibition 52 effector function 52 IIa trials 52 ATL# [001] 52 potently inhibits 52 OvaRex 52 RIGScan R 52 Artemisinin Combination Therapy 52 SURFAXIN r 52 VASCULAR 52 JAK2 inhibitor 52 HuCAL 52 3 registrational trial 52 VITAL Trial 52 deforolimus 52 Asthma COPD 52 pediatric acute lymphoblastic 52 Accessed #/#/# [001] 52 Vascugel R 52 samalizumab 52 EXPANSION OF 52 ADVEXIN therapy 52 HIV coinfected 52 Active Ulcerative Colitis 52 Postdoctoral Position 52 Pharmacokinetic Study 52 Biomarker Discovery 52 BC SeraPro TM 52 vidofludimus 52 TO EDUCATE 52 REMUNE R 52 THROUGH ITS 52 Nicotine Vaccine 52 Nat Rev 52 LIVERPOOL WILL NEVER 52 Orally administered 52 HCD# [002] 52 DRUG DISCOVERY 52 Removab 52 ularitide 52 Demonstrates Sustained 52 VATE 52 QuadraSphere 52 Resequencing 52 Neuroprotection 52 Protein Expression 52 Phase III confirmatory 52 Treatment Shows Promise 52 Oligonucleotide 52 SERCA2a 52 Solorel TM 51 Successfully Completes Phase 51 Pathogen Detection 51 G WHEEL 51 Study Evaluating 51 BCR ABL inhibitors 51 TGR5 51 HGS# 51 Arsenic trioxide 51 Glypromate 51 Alequel ™ 51 TO SOLUTIONS 51 Dendritic Cell 51 IN THRILLER 51 REMINYL ® 51 selective agonists 51 IIa trial 51 CobaCyte 51 imexon 51 Helps Predict 51 MET amplification 51 SET FOR MARCH 51 STUDENTS GET 51 HCV Protease Inhibitor 51 XL# SAR# 51 antiapoptotic 51 MorphoSys proprietary 51 Hsp# inhibition 51 number NCT# ClinicalTrials.gov 51 Optiquel ™ 51 ADVANCE ILLUMINATE 51 TREATMENT FOR 51 Atrisorb D R 51 carcinoembryonic antigen 51 PREVU 51 See CLINICAL PHARMACOLOGY 51 mutated K ras 51 YOUR E MAIL 51 Improves Outcomes 51 CAUGHT IN THE 51 Hedgehog antagonist 51 GOES GLOBAL 51 Anticancer Drug 51 MIST II 51 Sirenza logo 51 TLR agonists 51 ¿ HAY UN 51 Rosetta Elucidator 51 Genes Identified 51 TOEIC ® tests 51 YOUR AGE 51 TB Vaccine 51 INDON PRESIDENT 51 N DRV 51 HER2 Positive 51 evaluating carfilzomib 51 Microbial Detection 51 phase IIa clinical 51 FRONT RUNNING 51 chromosome #p# [002] 51 Therapy Improves 51 Oral Fingolimod 51 Clinical Trials Consortium 51 Pre Exposure Prophylaxis 51 aurora kinase inhibitor 51 Mimetics 51 Discoveries Tomorrow 51 Multiple Ascending Dose 51 AeroLEF TM 51 BNC# 51 Cancer Stem Cells 51 selective modulator 51 Phase 1b Clinical Trial 51 pharmacodynamic PD 51 Crit Rev 51 liposome formulation 51 refractory colorectal cancer 51 WHERE DOES IT 51 JAK#/JAK# inhibitor CYT# 51 SCANFLEX ® 50 WARFARIN 50 AUDIO PROVIDED BY 50 ARIKACE ™ 50 Tyrima 50 lamivudine resistant 50 SNT MC# 50 CANCER TREATMENT 50 Therapy Shows Promise 50 Tekmira SNALP technology 50 doxorubicin docetaxel 50 TRIST study 50 WOMEN WITH 50 Anticancer Agent 50 EXECUTIVE SUMMARY II 50 NexVas TM 50 Ultrafast Insulin 50 GRN# 50 NKX#.# 50 ACT 50 1T Flash 50 Circulating Tumor Cells 50 Therapeutic Antibodies 50 RDS R InCup 50 CCR2 50 AIR# [001] 50 Myoblast Program 50 Demonstrates Efficacy 50 Teva Provides Update 50 First Patient Enrolled 50 Hedgehog inhibitor 50 Progenitor Cells 50 Developmental Therapeutics 50 Fibromyalgia Syndrome 50 siRNAs targeting 50 subsidiaries Transatlantic Reinsurance 50 1am Timeless Music 50 Afatinib 50 phage display technology 50 Oncomine 50 mediated inhibition 50 online pharmacy CVS.com 50 Virulizin ® 50 BATTLES ON 50 OF THE CORPORATIONS 50 DIAGNOSTIC 50 XmAb# 50 STEM CELL 50 hitmaker BoB 50 Slows Progression 50 SOUTHERLY WINDS 50 #:# SPIKE Mon 50 recombinant albumin 50 Proellex TM 50 Theranostics 50 Gastrointestinal Stromal Tumors 50 ABSORB trial 50 Cardiometabolic 50 BroadSoft IMS compliant BroadWorks 50 Cancer Vaccines 50 CISSP CISSP ISSEP 50 MORE EFFECTIVE 50 Maven Semantic 50 STUDY FINDS 50 Breast Ultrasound 50 Hemopurifier ® 50 CCR5 antagonist 50 DISCUSSION AND POSSIBLE APPROVAL 50 human monoclonal antibody 50 peritoneal carcinomatosis 50 antibody humanization 50 selectively binds 50 fludarabine cyclophosphamide 50 nanopharmaceutical 50 ZFP 50 Optical Coherence Tomography 50 Pyridorin 50 Phenotyping 50 Spiegelmer ® 50 oxaliplatin Eloxatin 50 Therapeutic Targets 50 shaped Genmab 50 Lixivaptan 50 WAS STOPPED 50 kinase inhibition 50 Ophena 50 CRLX# 50 Protein Biomarker 50 FOX MTX 50 ADME PK 50 Drug Prevents 50 chemosensitivity 49 FDA Approves Drug 49 initiate Phase IIa 49 somatostatin receptor 49 TO BE SHOWN 49 Isolagen Process 49 RELOVAIR TM 49 SNALP formulations 49 PTI SJY 49 adenosine deaminase 49 undergoing elective percutaneous 49 Cytometry 49 indibulin 49 Improves Survival 49 Armour Banquet 49 BioMatrix TM 49 ImmuneY2 49 Cell Signaling 49 color cosmetics Almay 49 POLITICAL POWER 49 TGF Beta Shield 49 Fossilized remnants 49 trastuzumab emtansine T DM1 49 miRagen 49 gonadotrophin releasing hormone GnRH 49 Cannabinoid 49 AFTER WINNING THE 49 Combination Treatment 49 Circulatory Support 49 THOUSAND DOLLARS IN 49 Artistic Director Carey Perloff 49 WEEKLY PEEK AT 49 #:#-# [024] 49 tropism assay 49 oral NKTR 49 Demonstrates Positive 49 misfolded SOD1 49 trans retinoic acid ATRA 49 EOquin 49 BLA filing 49 Gentamicin Surgical Implant 49 ENTERTAINMENT IN BRIEF 49 CityHome 49 inhaled AAT 49 surgically resectable 49 Neoadjuvant Chemotherapy 49 Susceptibility Gene 49 LUNG CANCER 49 Artificial Pancreas 49 Molecular Genetic 49 multicenter clinical trials 49 Autoimmune Disease 49 Akt inhibitor 49 #:#-#,# CrossRef Medline [001] 49 WHAT ABOUT YOUR 49 rhFVIIa 49 PHONE MAST 49 Endocrinol 49 SHE CAN NOT 49 Protein Linked 49 Treatment Reduces 49 Musculoskeletal Diseases 49 retaspimycin 49 ComfortScan 49 MEMORIAL SERVICE FOR 49 Hormone Receptor Positive 49 ENVIRONMENTAL ASSESSMENT 49 UNITS FOR 49 Firazyr 49 potent stimulator 49 bortezomib Velcade 49 ganaxolone 49 sitaxsentan 49 AurSCOPE 49 radiosensitivity 49 aPTT 49 #:#.# Pacing 49 haematological cancers 49 radiolabeled 49 HCV protease inhibitors 49 HGS ETR2 49 cediranib 49 Genes Predict 49 TLR antagonists 49 Quadrivalent 49 #:# ENC Tue 49 BIO Pte Ltd 49 NeuRx DPS RA 49 PICKED FOR 49 thymidylate synthase TS 49 Disord 49 AXI TM 49 Bacille Calmette Guérin BCG 49 HALTS 49 ACTEMRA TM 49 ASTEROID 49 Virus Linked 49 Aethlon Medical Announces 49 gallium containing 49 anti fibrotic 49 Neurosurg 49 Glaucoma Treatment 49 PSN# [001] 49 HOUSE Remains 49 Peripheral Arterial 49 UPLYSO 49 PRESEPT study 49 CANCER RESEARCH 49 Prospective Randomized 49 Patient Registry 49 neuroprotective properties 49 selective kinase inhibitors 49 folate receptor 49 FUSILEV TM 49 glucagon receptor 49 #:# ENC Fri 49 estrogen receptor beta 48 TAXUS Express Stent 48 #-# Full Text 48 murine mouse 48 HOMES PLAN 48 Proves Effective 48 FirstLook pre feature 48 RECOGNITION FOR 48 GAP #B# 48 GLOBAL FUND 48 Online Stormreach 48 oral treprostinil 48 PROSTVAC ® 48 Radiological Threat 48 TRX1 48 tropism testing 48 #:# SPIKE Fri 48 sm energy.com 48 CRMD# 48 Systemic Sclerosis 48 hA# 48 Coagulation System 48 Non Invasive Treatment 48 Neuromodulation System 48 bioequivalency 48 DO YOU BELIEVE IN 48 #:# SPIKE Sat 48 Chemother 48 BEXXAR 48 #:# TMC Tue 48 MEDICAL INFORMATION 48 prostatic tissue 48 SINGER 'S 48 ® pioglitazone HCl 48 HEALTHY LIFE 48 Clinical Guideline 48 Zicam Allergy 48 PROSTATE CANCER 48 QTinno 48 STABILITY OF 48 OSLER 48 ACTIVE IN 48 Clostridium difficile Infection 48 Analytical Tool 48 Pitavastatin 48 ABOVE GROUND 48 NEUGENE antisense 48 Mouse Models 48 ALTAIR NANOTECHNOLOGIES 48 CIMZIA ™ 48 Xerecept 48 Microarray Scanner 48 IPL# 48 brivaracetam 48 International Ltd Ltée 48 Lung Injury 48 Announce Collaboration Agreement 48 Experimental Therapeutics Program 48 xanthine oxidase inhibitor 48 Edge STudy 48 circulating endothelial cells 48 p# Shc 48 Seconds Count 48 Platinum Chromium 48 Asia Container Terminals 48 STENT 48 Novel Therapeutics 48 Nuclear Receptors 48 Treating Chronic 48 sargramostim 48 immunomodulation 48 plasma renin activity 48 ASGCT 48 Plicera 48 EB# ® 48 #:# STZ Tue 48 Verax Platelet PGD 48 clonidine hydrochloride 48 MAXY alpha 48 VOLTAGE 48 Anticancer Agents 48 #:# STZ Sat 48 Hemostasis 48 QTinno TM 48 ChromeMate R 48 Psychiatry Clin Neurosci 48 CytoSure 48 IL 1ß 48 Application Compatibility Toolkit 48 Zavesca r 48 THE SITE BUY 48 Lamont Sale Sharks 48 Vaccine Immunology 48 Brown Waite Ginny 48 Tumor Microenvironment 48 #:# STZ Wed 48 ANAVEX #-# [001] 48 #:# MAX Tue 48 c myc gene 48 hematological parameters 48 Renal Insufficiency 48 REDUCTIONS IN 48 PDE4 inhibitors 48 LOST HIS 48 B. BAKER 48 VIBEX MTX 48 Protein Involved 48 #:# STZ Fri 48 YOU DRIVE 48 visit www.pancan.org 48 LB# [003] 48 HYC# 48 confirmatory clinical 48 Biomarker Discovery Center 48 photoprotective drug 48 Clinical Outcome 48 Corrigan Leinster 48 LV dysfunction 48 favorable pharmacokinetic profile 48 www.act 48 Phase 1b trial 48 #:# SHO Thu 48 clevidipine 48 dose dependently 48 Node Negative 48 #:# SHO Wed 48 cystinosis patients 48 Gene Mutation Linked 48 TAKES OUT 48 Inhaled Corticosteroids 48 AUTOMATIC FUEL INJECTED RED 47 PHOTO LIBRARY 47 DP b# 47 PENSION PLANS 47 Phase #b/#a 47 adenosine injection 47 Preclinical studies 47 #:# MAX Wed 47 mTOR inhibitors 47 biomarker assay 47 INTRODUCTION I. 47 Vasc 47 Harry Palmin President 47 lumiliximab 47 AWARENESS MONTH 47 YANKEES ARE 47 investigational antiplatelet 47 Biorepository 47 EVIZON ™ 47 Inhibitory 47 THERAPEUTIC 47 See #Z [003] 47 Compendia Bioscience 47 PEGPH# 47 MEDICATIONS 47 CORP DE 47 VaxImmune 47 PSAT SAT 47 elvucitabine 47 OF CHOICE 47 Recurrent Breast Cancer 47 America HFSA 47 CALGB 47 Autoimmune Diseases 47 homocysteine assay 47 DR MC# 47 Brain Tumor Therapy 47 naturally occurring peptide immunomodulator 47 Genomic Analysis 47 RenalGuard System TM 47 REMINDER ORLive Presents 47 symbol ARRO 47 mTOR inhibition 47 #:# ENC Sat 47 TimeSys OnBoard Program 47 cytokine refractory 47 labetuzumab 47 Investigator Initiated 47 Protein Microarray 47 Protein Interactions 47 www.ilgenetics.com 47 AND YOUTH 47 MYLOTARG 47 interferon beta therapy 47 Norm Referenced Test 47 #:# ENC Thu 47 SLx 47 Tumor Angiogenesis 47 schizophrenia CIAS 47 STOCKS AROUND THE 47 PART OF OUR 47 infrastructure includes Arcstar 47 drug eluting stent DES 47 Induced Pluripotent Stem Cells 47 Cellular Therapies 47 putative biomarkers 47 SAFE RETURN 47 Cogn 47 DNA Sequencer 47 Radiation Treatment 47 Cell Signalling 47 REAL ESTATE MARKET 47 BROADEN 47 #:# ENC Mon 47 J Consult Clin 47 SIRT1 enzyme 47 HuMax EGFr 47 AND THEY 'LL 47 #:# SYFY Sat 47 antiangiogenic activity 47 InterfeRx 47 Ph3 47 GOVT 'S 47 Nicotinic 47 SMALL PLANE 47 rindopepimut 47 Severe Asthma 47 WINNIPEG FREE PRESS ARCHIVES 47 antiangiogenic therapy 47 Study Casts Doubt 47 TMUS EPA 47 Robins AFB Warner Robins 47 REGISTRATION IS 47 rubella hepatitis 47 Protein Structure 47 Oncotype DX Recurrence Score 47 statistically significant efficacy 47 relapsed ALL 47 ENRICH 47 MATH AND 47 DUTY OF 47 Long Term Efficacy 47 Significantly Improves 47 MoxDuo 47 Pharmacokinetic studies 47 ENH neutral 47 operative atrial arrhythmia 47 evaluating ambrisentan 47 Screenings Offered 47 N GRN 47 NSW VIC 47 taxane therapy 47 Hereditary Breast 47 demonstrated clinically meaningful 47 ALV# 47 Milestone patented CompuFlo 47 PTHrP 47 Targeted Therapy 47 CAN YOU DESCRIBE 47 INT# [002] 47 AND SERVE 47 SF #v# 47 IL #E 47 DIAGNOSTICS 47 singer Dalvin DeGrate 47 UVIDEM 47 #:# ENC Wed 47 Gene Linked 47 QVAR 47 #:# TMC Thu 46 ASONEP 46 DANFORTH MUSEUM OF 46 CytoFabTM 46 ONCOLOGY 46 #:# SYFY Tue 46 ulimorelin 46 Prognostic Value 46 #:# SYFY Wed 46 Lowers Risk 46 RNA Interference 46 #:# SHO Fri 46 MEND CABG II 46 Canada statefarm.ca R 46 CURE FOR 46 NEW STUDY 46 #:# STZ Mon 46 MOLECULAR 46 Genes Linked 46 desorption electrospray ionization 46 intravenous CK # 46 GATTEX ® 46 TLE3 46 YOKNEAM Israel Mellanox 46 Mol Med 46 MICROSCOPE 46 pharmacokinetic PK profile 46 #:# ABCFAM Sat 46 #:# STZ Thu 46 Polymer Material 46 PRESEPT 46 Schizophrenia Treatment 46 alpha7 NNR 46 Acute Myocardial Infarction 46 Cinquil 46 #:#-#,# CrossRef Medline [002] 46 AGAINST CANCER 46 Ocular Inflammation 46 Signal Transduction 46 R# R#e 46 Cardiol 46 #:# TMC Wed 46 DNA demethylation 46 EQUITY RESEARCH 46 Individualized Therapy 46 CINOD 46 Bone Metastases 46 Arisaph 46 Biologic Therapy 46 #:# SHO Tue 46 Post Operative 46 Prospective Multicenter 46 #:#-# [001] 46 #:# SYFY Fri 46 PROGRAM COORDINATOR 46 #:# TMC Mon 46 Cancer Immunotherapeutics 46 TO SPEAK ON 46 Arterial Disease 46 Urocidin 46 Ovarian Cancer Patients 46 JMFA Overdraft Privilege 46 Services #:#-#,# Abstract 46 hematological tumors 46 EOE M F 46 fibrotic disease 46 ANN INTERN MED 46 Pharmacokinetic parameters 46 FEEDING FRENZY EPISODE 46 INFORMATICS 46 TECHNOLOGIST 46 Pharmacogenetics 46 Acute Heart Failure 46 MARTENS 46 antiandrogen 46 Dr. Bahcall 46 Endeavor DES 46 intranasal insulin 46 Erosive 46 Childhood Asthma 46 #:# MAX Thu 46 OMAPRO 46 Exp Clin 46 Limb Preservation 46 AERx iDMS 46 Preclinical Evaluation 46 tipranavir r 46 Conquering Cancer 46 gene rearrangements 46 Toraymyxin TM 46 #:#-# [023] 46 SKIN CANCER 46 Cognitive Deficits 46 DCCR 46 canakinumab 46 generation FBPase inhibitor 46 Often Misdiagnosed 46 VIDAZA ® 46 siRNA mediated 46 pharmacokinetic equivalence 46 Psychol 46 CANCER PATIENTS 46 Angiox ® 46 imatinib therapy 46 ARTIST UNKNOWN TWENTIETH CENTURY 46 BIOMEDICAL 46 YOUR CHARACTER 46 visit www.health.state.pa.us 46 IN BELGIUM 46 Lyn kinase 46 PRINT AND 46 BCMM 46 genotoxicity 46 Trofile assay 46 vivo potency 46 Cell Adhesion 46 prognostic indicators 46 Discovery Labs KL4 46 Sebastien Ogier Citroen C2 46 CNS Disorders 46 THE ADOPTION OF 46 #:# SHO Mon 46 Targeted Therapies 46 By RELMA HARGUS 46 ON CLIMATE 46 botanically derived 46 Post Menopausal 46 Genes Discovered 46 Lowering Blood Pressure 46 recurrent glioblastoma 46 Cosimo Cutri 46 Molecular Origins 46 J Nutr 46 Slow Progression 46 CPTR 46 Percutaneous Tibial Nerve Stimulation 46 Aerovant 46 BeneFIX 46 SENATE APPROVES 46 Neuropsychol 46 Cre recombinase 46 Aggressive Reduction 46 Vectibix panitumumab 46 PARKINSON 'S 46 PARKINSON 'S DISEASE 46 Novel Treatments 46 UNDERWAY IN 46 Valortim ® 46 Novel Peptide 46 AMYLIN 46 Asthma Intervention 45 ID Seq 45 SCENES FROM THE 45 punctal plug 45 CLL8 45 Solasia 45 Rhinosinusitis 45 digital mammography tomosynthesis 45 AND ECONOMIC 45 GROWS IN 45 Genetic Variation 45 GetGoal 45 2 methoxyestradiol #ME# 45 bucindolol 45 FOR IMPROVED 45 FOR PATIENTS 45 COGNEX 45 Efficiently Manage 45 CRIME RATE 45 MET inhibitor 45 MYTHOS trial 45 Observational Study 45 Myocardial Perfusion 45 KATRINA VICTIMS 45 SET FOR SATURDAY 45 Magnetic Stimulation 45 Patient Focused 45 coexpression